Blumenthal named VP of Global Oncology Regulatory Affairs at Merck

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Gideon Blumenthal was named vice president for Global Oncology Regulatory Affairs at Merck.

He is a former deputy director of the FDA Oncology Center of Excellence.

Table of Contents

YOU MAY BE INTERESTED IN

The California Institute for Regenerative Medicine, a state agency tasked with awarding billions of dollars of scientific funding for stem cell and gene therapy, has rescinded a controversial policy that was disrupting the flow of funding to cancer research.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login